Regulation and Deregulation of Industry – Page 205 – MOSAEC

How Silicon Valley Bank’s Failure Could Have Spread Far and Wide

Banking and Financial Institutions Deposit Insurance Federal Reserve System Regulation and Deregulation of Industry Signature Bank Silicon Valley Bank United States Economy

How Silicon Valley Bank’s Failure Could Have Spread Far and Wide

New research suggests large parts of the country remain vulnerable to widespread bank failure in the event of a run on deposits.

By Jim Tankersley

What to Know About Buying Electric Cars and the New Emissions Rule

Content Type: Service Electric and Hybrid Vehicles Environmental Protection Agency Fuel Efficiency Fuel Emissions (Transportation) Global Warming Greenhouse Gas Emissions Oil (Petroleum) and Gasoline Personal Finances Regulation and Deregulation of Industry Tax Credits, Deductions and Exemptions

What to Know About Buying Electric Cars and the New Emissions Rule

Here is what car buyers need to know about the Biden administration’s proposal to push the auto industry to sell more electric cars.

By Vikas Bajaj

Why Drugmakers’ Abortion Pill Battle is Such a Big Deal

Bank of America Corporation Buffett, Warren E Credit Suisse Group AG Decisions and Verdicts Doerr, John Federal Reserve Bank of New York Federal Reserve System Food and Drug Administration Gershkovich, Evan Home Box Office internal-storyline-no Kacsmaryk, Matthew Moritz, Michael Jonathan Musk, Elon Newsom, Gavin Ocasio-Cortez, Alexandria Regulation and Deregulation of Industry Silicon Valley Bank Supreme Court (US) Tesla Motors Inc Twitter UBS AG Warner Bros Discovery Warner Media LLC Warren, Elizabeth Winklevoss, Cameron;Winklevoss, Tyler

Why Drugmakers’ Abortion Pill Battle is Such a Big Deal

The decision by a Texas judge to overturn F.D.A. approval for the abortion pill mifepristone could upend the pharmaceutical industry.

By RSS Feed

Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Decisions and Verdicts Drugs (Pharmaceuticals) Federal-State Relations (US) Food and Drug Administration mifepristone Regulation and Deregulation of Industry Suits and Litigation (Civil) Supreme Court (US)

Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.

By Christina Jewett and Pam Belluck